Recent Observations on Gaucher’s Disease
Gaucher’s disease has been classically defined biochemically as having an accumulation of glucosylceramide in concert with a decreased associated hydrolytic enzyme activity (1) in tissues from affected individuals. This reduced enzymatic activity was originally demonstrated using glucosylceramide as substrates (2) however, p-nitrophenol (pNP) or 4 methylumbelliferyl (4MU) β-glucose (3) and glucosylsphinogosine (4) cleavage are also reduced in tissue samples from affected individuals.
KeywordsControl Brain Acid Hydrolase Metachromatic Leukodystrophy Glucosidase Activity Hydrolytic Enzyme Activity
Unable to display preview. Download preview PDF.
- 1.Fredrickson, D. S. and Sloan, H. R. in Metabolic Basis of Inherited Diseases, (ed. Stanbury, J. B., Wyngaarden, J. B. and Fredrikson, D. S.) McGraw-Hill, New York, 730, 1972.Google Scholar
- 3.Patrick, A. D., Biochem. J. 97, 17c (1965).Google Scholar
- 5.Brady, R. O., Kanfer, J. N. and Shapiro, D. J., Biol. Chem. 240, 39 (1965).Google Scholar
- 6.Mumford, R. A., Raghavan, S. S. and Kanfer, J. N., J. Neurochem. in the press.Google Scholar
- 13.Mallor, J. D. and Layne, D. S., J. Biol. Chem. 246, 4377 (1971).Google Scholar
- 15.Mumford, R. A., Raghavan, S. S., and Kanfer, J. N., submitted for publication.Google Scholar
- 16.N. E. J. Med. Sept. 14, 1961, pg. 546.Google Scholar
- 18.Souami, E. D. and Agranoff, B. W., J. Lipid Res. 6, 211 (1965).Google Scholar